| Title |
Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
|
|---|---|
| Published in |
PLOS ONE, April 2008
|
| DOI | 10.1371/journal.pone.0001928 |
| Pubmed ID | |
| Authors |
Friedemann Paul, Sonia Waiczies, Jens Wuerfel, Judith Bellmann-Strobl, Jan Dörr, Helmar Waiczies, Mareile Haertle, Klaus D. Wernecke, Hans-Dieter Volk, Orhan Aktas, Frauke Zipp |
| Abstract |
Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicated a possible beneficial impact of statins on MS. |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Unknown | 66 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 15% |
| Other | 8 | 12% |
| Student > Ph. D. Student | 8 | 12% |
| Student > Postgraduate | 6 | 9% |
| Professor | 5 | 7% |
| Other | 19 | 28% |
| Unknown | 11 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 42% |
| Agricultural and Biological Sciences | 5 | 7% |
| Neuroscience | 4 | 6% |
| Immunology and Microbiology | 4 | 6% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Other | 8 | 12% |
| Unknown | 15 | 22% |